THE PRESENCE OF M2 MACROPHAGES IN OVARIAN CANCER IS INFLUENCED BY TUMOR STAGE AND GRADE, NOT BY THE ADMINISTRATION OF PACLITAXEL-CARBOPLATIN: A PILOT STUDY

被引：0
|
作者：
Baert, T. [1 ]
Mathivet, T. [2 ]
Van Hoylandt, A. [3 ]
Vergote, I. [1 ]
Coosemans, A. [1 ]
机构：
[1] Univ Hosp Leuven, Gynaecol & Obstet, Leuven, Belgium
[2] Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Vasc Patterning, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Oncol, Lab Gynaecol Oncol, Leuven, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1130
引用
收藏
页码：1282 / 1282
页数：1
相关论文
共 50 条
  • [1] A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer
    Taisuke Mori
    Kenichi Hosokawa
    Yoshiyuki Kinoshita
    Ai Watanabe
    Takeshi Yamaguchi
    Haruo Kuroboshi
    Yoshiko Kato
    Jinsuke Yasuda
    Hiroyuki Fujita
    Yoshinori Nakata
    Hideo Honjo
    International Journal of Clinical Oncology, 2007, 12 : 205 - 211
  • [2] A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer
    Mori, Taisuke
    Hosokawa, Kenichi
    Kinoshita, Yoshiyuki
    Watanabe, Ai
    Yamaguchi, Takeshi
    Kuroboshi, Haruo
    Kato, Yoshiko
    Yasuda, Ansuke
    Fujita, Hiroyuki
    Nakata, Yoshinori
    Honjo, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (03) : 205 - 211
  • [3] A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    Adachi, S
    Ogasawara, T
    Ito, K
    Koyama, M
    Nagano, T
    Suzuki, A
    Yamada, T
    Nakata, Y
    Ozawa, M
    ONCOLOGY REPORTS, 2001, 8 (02) : 285 - 288
  • [4] Consolidation docetaxel after paclitaxel-carboplatin chemotherapy in stage Ic-IV ovarian cancer.
    Matsumoto, R.
    Isonishi, S.
    Suzuki, M.
    Nagano, H.
    Takagi, K.
    Ochiai, K.
    Tanaka, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer
    Isonishi, Seiji
    Suzuki, Masaaki
    Nagano, Hiroaki
    Takagi, Koichiro
    Shimauchi, Masahito
    Kawabata, Masakiyo
    Ochiai, Kazuhiko
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (02) : 154 - 159
  • [6] RANDOMIZED PHASE II STUDY OF PACLITAXEL-CARBOPLATIN (PC) VERSUS GEMCITABINE-CARBOPLATIN (GC) FOLLOWED BY PACLITAXEL-CARBOPLATIN (PC) IN PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA (PSROC): A GEICO (SPANISH GROUP FOR INVESTIGATION IN OVARIAN CANCER) STUDY
    Martin, A. Gonzalez
    Casado, A.
    Arranz, J.
    Rubio, M. J.
    Calvo, E.
    Beltran, M.
    Mendiola, C.
    Sanchez, A.
    Santaballa, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 307 - 307
  • [7] Mast cells and M2 macrophages in ovarian cancer
    Jammal, Millena Prata
    Lopes, Ananda Domingues
    Etchebehere, Renata Margarida
    Candido Murta, Eddie Fernando
    Nomelini, Rosekeila Simoes
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (07) : 3094 - 3100
  • [8] Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer
    Micha, JP
    Goldstein, BH
    Rettenmaier, MA
    Mattison, J
    Graham, C
    Birk, CL
    Brown, JV
    GYNECOLOGIC ONCOLOGY, 2004, 94 (03) : 719 - 724
  • [9] Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer A retrospective, STROBE-compliant study
    Wang, Fei
    Du, Xuelian
    Li, Xiaoxia
    Liu, Naifu
    Yu, Hao
    Sheng, Xiugui
    MEDICINE, 2016, 95 (51) : e5696
  • [10] Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer:: A phase II study
    Mäenpää, JU
    Grénman, SE
    Jalkanen, JT
    Kuoppala, TA
    Leminen, AO
    Puistola, US
    Vuolo-Merilä, PM
    Yliskoski, MH
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 114 - 119
12345